Metabolite Profiling of Talatisamine in Heart Tissue After Oral Administration and Analysis of Cardiac Bioactivities
Planta Medica · 01.05.2023 · 89 (06) · 674-682
DOI: 10.1055/a-1956-7542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.05.2023. Verfasst von Shuai Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Engineering Southwest Jiaotong University, Chengdu, Sichuan, P. R. China. Hauptthemen laut MEDLINE: Alkaloids, Diterpenes, Aconitum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: the Fundamental Research Funds for Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
The lateral roots of the Aconitum carmichaelii (“Fuzi”) have been used for centuries as a cardiotonic in China. The diterpenoid alkaloid talatisamine (TA) is a major bioactive component of Fuzi, but the identity and bioactivities of the TA metabolites have not been examined in detail. In this study, metabolite profiling of TA was performed in rat heart by UPLC-MS following oral administration. Metabolites were identified by comparing protonated molecules, fragmentation patterns, and chromatographic behaviors with those of standard compounds. Metabolites of TA were then prepared and tested for cardiotonic activity on isolated frog hearts. The metabolite cammaconine, a C19 diterpenoid alkaloid with a hydroxyl group at C-18, exhibited substantial cardiotonic activity during frog heart perfusion. To further investigate the structure–cardiac effect relationships, a series of C19-diterpenoid alkaloids with 18-OH were prepared. Eight tested compounds (5–12) demonstrated measurable cardioactivity, of which compound 5 with an N-methyl group and compound 7 with a methoxy at C-16 showed stronger effects on ventricular contraction than the other compounds. Thus, 18-OH is a critical structural feature determining cardiotonic activity, and efficacy is improved by the presence of N-methyl or methoxy at C-16. Preliminary mechanistic studies suggested that the cardiotonic effect of compound 5 is mediated by enhanced cellular calcium influx. Metabolites of TA with these structural features may be useful therapeutics to prevent heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Science and Engineering Southwest Jiaotong University, Chengdu, Sichuan, P. R. China.
- Yibin Institute of Southwest Jiaotong University, Yibin, Sichuan, P. R. China.
- The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, P. R. China.
ORCID-Profile: Shuai Huang
Förderung
- the Fundamental Research Funds for Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Huang, S., Lv, Y., Wang, J. Z., Ye, M. Z., Lu, R. J., Chen, L., Xie, J., Gao, F., & Zhou, X. L. (2023). Metabolite Profiling of Talatisamine in Heart Tissue After Oral Administration and Analysis of Cardiac Bioactivities. Planta Medica, 89(06), 674-682. https://doi.org/10.1055/a-1956-7542
Vancouver
Huang S, Lv Y, Wang JZ, Ye MZ, Lu RJ, Chen L, et al. Metabolite Profiling of Talatisamine in Heart Tissue After Oral Administration and Analysis of Cardiac Bioactivities. Planta Medica. 2023;89(06):674-682. doi:10.1055/a-1956-7542
BibTeX
@article{Huang2023,
author = {Huang, Shuai and Lv, Yang and Wang, Jian-Zhu and Ye, Mei-Zhen and Lu, Rui-Jie and Chen, Lin and Xie, Jiang and Gao, Feng and Zhou, Xian-Li},
title = {Metabolite Profiling of Talatisamine in Heart Tissue After Oral Administration and Analysis of Cardiac Bioactivities},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {06},
pages = {674--682},
doi = {10.1055/a-1956-7542}
}
EUVIMED